Finally, an increasing number of immunohistochemical markers are being utilized in the identification of basal-like and BRCA1-related breast cancers [18,29-31], and further validation of these additional markers will be required if they are also to be used as a guide to clinical prognosis and therapeutic choices [14]. The gene discussed is BRCA1; the disease is breast carcinoma.